| Lake Superior Hospice Association 914 West Baraga, Marquette, MI, 49855 | |
| (906) 225-7760 |
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| Name | Lake Superior Hospice Association |
|---|---|
| Location | 914 West Baraga, Marquette, Michigan |
| Hospice ID | 231553 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 510 |
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| NPI Number | 1942272422 |
| Organization Name | Lake Superior Hospice Association Inc |
| Address | 914 W Baraga Ave Marquette, Michigan, 49855 |
| Phone Number | (906)225-7760 |
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 96.4 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 77.4 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 92.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 79.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 96.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 52.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.2 | 93.3 |
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| Home Health Aides | 2.7 |
| Counselors | 1 |
| Medical Social Workers | 2.4 |
| Registered Nurses | 7 |
| Other Personnel | 5.1 |
| Total Employees | 18.2 |
|---|
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| Homemakers | 0.2 |
| Licensed Practical or Vocational Nurses | 0.1 |
| Physicians | 0.3 |
| Registered Nurses | 0.2 |
| Others | 0.5 |
| Total Volunteers | 1.3 |
|---|
News Archive
Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.
In May 2009 RaySearch Laboratories entered into a long-term development and licensing agreement with Siemens Healthcare. Under the agreement RaySearch provided a number of treatment planning modules for integration in Siemens' syngo Suite for Oncology, which is Siemens' integrated workflow solution for radiation therapy.
For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia with relapsed or refractory disease.
St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in the June 15 edition of the scientific journal Genes & Development.
› Verified 2 days ago
| Lake Superior Hospice Association Location: 914 West Baraga, Marquette, Michigan, 49855 Phone: (906) 225-7760 |
| Upper Peninsula Home Health & Hospice Location: 1125 W Ridge St, Marquette, Michigan, 49855 Phone: (906) 225-7760 |